Knockdown of FOXO1 accelerated ROS accumulation and led to significantly higher levels of ROS compared to the control (Figure 1A), while FOXO1overexpression significantly reduced ROS levels (Supplementary Figure S1A), suggesting that FOXO1 could affect ROS levels in tumor cells. Here, FOXO1 is linked to neoplasm.